Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
for targeted protein degradation with relevance to cancer biology and therapy. Your responsibilities will include: Designing and conducting biochemical and cell‑based high‑throughput screens Structure‑guided
-
with large-scale neuroimaging and multimodal datasets. You will design and conduct neuroimaging analyses, coordinate data processing pipelines, and perform advanced statistical and computational analyses
-
in model organisms, and the curative gene correction of immunodeficiency patients carrying mutations in the BTK gene. The candidate is expected to participate in experimental design, logistics, sample
-
systematically identify risk factors for psychiatric ill health in autistic people, using exposeome-wide methods. You will be involved in all aspects of the research process, including study design, data
-
‑related aspects of nervous system function: https://ki.se/en/neuro/research/group-leaders-at-the-department-of-neuroscience SciLifeLab is a national research infrastructure providing unique technologies and
-
expression levels. Integration of molecular and cellular readouts to identify disease-driving pathways and potential intervention points You are expected to plan and perform experiments independently, analyse
-
from national health registers. You will work independently with study design, programming, analysis, and reporting, with input from experts in clinical, biomedical, and statistical aspects. Your profile
-
multiomics and designed a targeted intervention to elicit such potential (Llorens-Bobadilla et al. Science 2020). In parallel, we also develop novel technologies for spatially-resolved multiomics (Llorens
-
publications see here: https://www.scilifelab.se/researchers/stefanos-stagkourakis/ Essential technical expertise (Required) This position is intended for candidates who can immediately operate at a high
-
studies, we are actively involved in the design and implementation of clinical trials, with the goal of improving prognosis and developing more effective therapies for patients. More information about our